Safety of Topical Tranexamic Acid in Total Joint Arthroplasty in High Risk Patients

Clinical Trial ID NCT02644473

PubWeight™ 0.00‹?›

🔗 Visit the ClinicalTrials.gov page for NCT02644473

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial. J Bone Joint Surg Am 2010 2.89
2 Use of tranexamic acid for an effective blood conservation strategy after total knee arthroplasty. Br J Anaesth 1999 1.49
3 Tranexamic acid: a review of its use in the treatment of hyperfibrinolysis. Drugs 2012 1.46
4 The effect of tranexamic acid on blood loss and use of blood products in total knee arthroplasty: a meta-analysis. Knee Surg Sports Traumatol Arthrosc 2011 1.26
5 Combination of intravenous and topical application of tranexamic acid in primary total knee arthroplasty: a prospective randomized controlled trial. J Arthroplasty 2014 1.03
6 Topical (intra-articular) tranexamic acid reduces blood loss and transfusion rates following total hip replacement: a randomized controlled trial (TRANX-H). J Bone Joint Surg Am 2013 1.01
7 Preliminary results suggest tranexamic acid is safe and effective in arthroplasty patients with severe comorbidities. Clin Orthop Relat Res 2014 0.87
8 Venous thromboembolism and mortality associated with tranexamic acid use during total hip and knee arthroplasty. J Arthroplasty 2014 0.86
Next 100